"Jmol and the CDK add powerful chemical capabilities", says Munos in Nature Reviews Drug Discovery
Creators & Contributors
Bernard Munos at Eli Lilly & Co. wrote up a lengthy analysis on open source in drug discovery in Nature Reviews Drug Discovery: Can open-source R&D reinvigorate drug research? (DOI:10.1038/nrd2131). When scanning the article I saw this quote:
Other tools such as eMolecules, Jmol or the Chemistry Development Kit are adding powerful chemical search and visualization capabilities to the open-source scientist's toolbox.
Unfortunately, the paper does not point to the correct CDK website, but to the CUBIC backend at http://almost.cubic.uni-koeln.de/cdk. Moreover, I don't think the quote does full justice to what the CDK has achieved in the past six years; I'm sure we have achieved more than a fingerprinter and some 2D and 3D rendering!
Additional details
Description
Bernard Munos at Eli Lilly & Co. wrote up a lengthy analysis on open source in drug discovery in Nature Reviews Drug Discovery: Can open-source R&D reinvigorate drug research?
Identifiers
- UUID
- 8140d6cf-f058-4c1b-865b-c2747aa29748
- GUID
- https://doi.org/10.59350/gh2mq-4qc75
- URL
- https://chem-bla-ics.linkedchemistry.info/2006/09/13/jmol-and-cdk-add-powerful-chemical.html
Dates
- Issued
-
2006-09-13T00:00:00
- Updated
-
2025-02-16T00:00:00